BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28185930)

  • 1. Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method.
    Gomathi T; Sudha PN; Florence JAK; Venkatesan J; Anil S
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1820-1832. PubMed ID: 28185930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Size optimization and in vitro biocompatibility studies of chitosan nanoparticles.
    Thandapani G; P SP; P N S; Sukumaran A
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1794-1806. PubMed ID: 28807691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
    Joseph JJ; Sangeetha D; Gomathi T
    Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
    Motiei M; Kashanian S
    Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
    Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
    Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
    Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of encapsulated peppermint and green tea essential oils in chitosan nanoparticles: Encapsulation, thermal stability, in-vitro release, antioxidant and antibacterial activities.
    Shetta A; Kegere J; Mamdouh W
    Int J Biol Macromol; 2019 Apr; 126():731-742. PubMed ID: 30593811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
    Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
    Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
    Vandana M; Sahoo SK
    Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study.
    Hosseini SF; Zandi M; Rezaei M; Farahmandghavi F
    Carbohydr Polym; 2013 Jun; 95(1):50-6. PubMed ID: 23618238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
    Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
    Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 14. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
    Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
    Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
    Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
    Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumatriptan succinate loaded chitosan solid lipid nanoparticles for enhanced anti-migraine potential.
    Hansraj GP; Singh SK; Kumar P
    Int J Biol Macromol; 2015 Nov; 81():467-76. PubMed ID: 26299709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
    Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
    J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study.
    Delan WK; Zakaria M; Elsaadany B; ElMeshad AN; Mamdouh W; Fares AR
    Int J Pharm; 2020 Mar; 577():119038. PubMed ID: 31953085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.